Recombinant Human BTLA Protein, C-hFc and His tag
- 
									
产品编号
KMH760
 - 
									
别名
BTLA受体BTLA1, CD272, B and T lymphocyte associated
 - 
									
规格
- 20ug
 - 50ug
 - 100ug
 - 200ug
 - 1mg
 
 
| Catalog Number | KMH760 | 
| Alias | BTLA受体BTLA1, CD272, B and T lymphocyte associated | 
| Size | 20ug, 50ug, 100ug, 200ug, 1mg | 
| Product Description | KMH760 Recombinant Human BTLA Protein, C-hFc and His tag contains the human BTLA(Lys31-Thr134) was expressed in Mammalian cells. | 
| Molecular Name | BTLA | 
| Product Introduction | (KMH760) BTLA是免疫检查点分子,调节免疫耐受和免疫逃逸。 | 
| Molecular Weight | 50-60 kDa | 
| Expression System | HEK293F Cells | 
| Species | Human | 
| Concentration | 联系销售经理获得最新批次的浓度 | 
| Purity | ≥95% | 
| SDS-PAGE | ![]()  | 
| Purification | Affinity Purification | 
| Uniprot ID | Q7Z6A9-2 | 
| Storage Condition | Store the product under sterile conditions after opening at -80℃ for 12 months. Store the lyophilized powder at -20℃. Avoid repeated freeze-thaw cycles. | 
| Formulation | PBS | 
| Shipping Condition | This product is shipped on ice packs or dry ice. | 
| Background | BTK (also known as Bruton tyrosine kinase) plays a crucial role in B-lymphocyte differentiation and activation. BTK interacts with SRC homology 3 domains of FYN, LYN and HCK that are activated upon stimulation of B- and T-cell receptors. Defects in the BTK gene cause Agammaglobulinemia, an X-linked immunodeficiency characterized by failure to produce mature B lymphocyte cells and associated with a failure of Ig heavy chain rearrangement. The unique role of BTK makes it a desirable target for potential anti-cancer, anti-inflammatory and anti-viral agents as well as other treatments. | 
| Endotoxin | < 0.1 EU per ug | 
| Protein Family | Other protein | 
| Biological Activity | Immobilized Recombinant human BTLA at 3 μg/mL (100 μL/well) can bind Biotinylated Recombinant human HVEM with a linearrange of 18-72 ng/mL. | 
| Product Declaration | 该产品仅供科研使用,不可直接用于人体或注射。 | 
							
							
							
							
						
								0